Hostname: page-component-5cf477f64f-54txb Total loading time: 0 Render date: 2025-03-26T17:57:41.404Z Has data issue: false hasContentIssue false
  • English
  • Français

Suicide and the cost-effectiveness of antidepressants

Published online by Cambridge University Press:  02 January 2018

J. A. Henry
J. A. Henry*
Affiliation:
Medical Toxicology Unit, Guy's and St Thomas' Hospital Trust, Avonley Road, London SEI4 5ER
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 170 , Issue 1 , January 1997 , pp. 88
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

References

Edwards, J. C. (1995) Suicide and antidepressants. British Medical Journal. 310, 205–206.Google Scholar
Henry, J. A. (1996) Suicide risk and antidepressant treatment. Journal of Psychopharmacology 19, 39–40.Google Scholar
Henry, J. A., Alaxander, C. A. & Sener, E. K. (1995) Relative mortality from overdose of antidepressants. British Medical Journal, 310, 221–224.Google Scholar
Hotopf, M., Lewis, G. & Normand, C. (1996) Are SSRIs a cost-effective alternative to tricyclics? British Journal of Psychiatry 168, 404–409.CrossRefGoogle ScholarPubMed
O'Donnell, I. & Farmer, R. (1995) The limitations of official suicide statistics. British Journal of Psychiatry 166, 458–461.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.